Maastricht University Medical Center
Maastricht, Limburg, 6202 AZ, Netherlands
NCT Number: NCT01198015
Rett syndrome (RTT) is an X-linked severe neurodevelopmental disorder. Despite their good appetite, many females with RTT meet the criteria for moderate to severe malnutrition. The pathological mechanism is barely understood. Although feeding difficulties may play a role in this, other constitutional factors as altered metabolic processes are suspected. Preliminary research showed elevated plasma creatine concentrations and increased urinary creatine/creatinine ratios in half of the RTT girls.
The aim of this study is to confirm previous findings and examine the functionality of the creatine transporter in RTT girls.
The investigators assume that previous findings will be confirmed, and are due to an altered functionality of the creatine transporter.
Looking for future studies?
Notify Me3 year–20 year
Female
Observational
Maastricht, Limburg, 6202 AZ, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One hour
Blood as well as urine samples will be collected to confirm previous findings concerning plasma and urine creatine concentrations. Furthermore, blood samples will be used to perform mutation analysis of the SCL6A8 gene. Secondary, a skin biopsy will be collected for functional studies regarding the creatine transporter in RTT girls. By comparing intracellular and extracellular creatine concentrations, one can assess the functionality of the creatine transporter.
Maastricht University Medical Center
Other
Metabolic Evaluation of Nutrition in Rett Syndrome: Creatine Metabolism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06199700
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Xiamen, Fujian, China
View Trial DetailsNCT06849973
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
La Jolla, California, United States
View Trial DetailsNCT04514549
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Boston, Massachusetts, United States
View Trial DetailsNCT03633058
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Birmingham, Alabama, United States
View Trial Details